Handbook home
Drug Treatment of Disease (PHRM30003)
Undergraduate level 3Points: 12.5On Campus (Parkville)
About this subject
- Overview
- Eligibility and requirements
- Assessment
- Dates and times
- Further information
- Timetable(opens in new window)
Contact information
Semester 2
Subject Coordinator
Assoc Prof Christine Wright
Dr Graham Mackay
Administrative Coordinator
BiomedSci-AcademicServices@unimelb.edu.au
Overview
Availability | Semester 2 |
---|---|
Fees | Look up fees |
Cancer, disorders of the immune system, cardiovascular diseases and acute and chronic lung disorders are the most common types of afflictions affecting people worldwide. This subject will examine the medicines that have been developed, or are currently being researched, to treat these diverse conditions.
This subject will present the scientific basis of present and likely future treatments of cancer, allergy, acute and chronic inflammation, infection, autoimmunity and transplant rejection, as well as of hypertension, heart failure, cardiovascular atheromatous disease and metabolic syndrome.
You will examine current knowledge of the pathogenesis of these disorders and the mechanisms of action of the major classes of drugs used to treat immune disorders, cancer, cardiovascular and respiratory diseases will be considered in the context of these systems and processes. The importance of biotechnology to these therapeutic areas will also be considered.
Intended learning outcomes
- On successful completion of this unit, students will have developed a solid understanding of the pharmacology of drugs used to treat immunological, oncological, cardiovascular and respiratory disorders.
- Students will also gain an appreciation of how a detailed understanding of pathological processes is important for the rational development of new therapeutic drugs.
Generic skills
By the end of this unit students will:
- Have an understanding of the scientific basis of the action of drugs.
- Be adept at learning in a range of ways.
- Be able to examine critically, synthesise and evaluate knowledge pertaining to drugs.
- Be able to integrate key pharmacological and immunological principles.
- Participate in collaborative learning.
- Have a broad understanding of the process of drug development and utilisation, with a high regard for ethics and safety.
Last updated: 27 April 2024
Eligibility and requirements
Prerequisites
BSc students:
Code | Name | Teaching period | Credit Points |
---|---|---|---|
PHRM20001 | Pharmacology: How Drugs Work | Semester 2 (On Campus - Parkville) |
12.5 |
BBiomed students:
Code | Name | Teaching period | Credit Points |
---|---|---|---|
BIOM20002 | Human Structure and Function | Semester 2 (On Campus - Parkville) |
25 |
Students wishing to undertake this subject as breadth will need the approval of the subject co-ordinator.
Corequisites
None
Non-allowed subjects
This subject cannot be taken if credit has been previously obtained for 534-304 Pharmacology of Therapeutic Substances.
Inherent requirements (core participation requirements)
The University of Melbourne is committed to providing students with reasonable adjustments to assessment and participation under the Disability Standards for Education (2005), and the Assessment and Results Policy (MPF1326). Students are expected to meet the core participation requirements for their course. These can be viewed under Entry and Participation Requirements for the course outlines in the Handbook.
Further details on how to seek academic adjustments can be found on the Student Equity and Disability Support website: http://services.unimelb.edu.au/student-equity/home
Last updated: 27 April 2024
Assessment
Additional details
- Continuing assessment (20%)
- Workshop participation (10%)
- A 2 hour written examination in the examination period (70%)
Last updated: 27 April 2024
Dates & times
- Semester 2
Principal coordinator Christine Wright Coordinator Graham Mackay Mode of delivery On Campus (Parkville) Contact hours 3 x one hour lectures per week. Workshops will be held in lecture slots (total contact hours: 36) Total time commitment 170 hours Teaching period 24 July 2017 to 22 October 2017 Last self-enrol date 4 August 2017 Census date 31 August 2017 Last date to withdraw without fail 22 September 2017 Assessment period ends 17 November 2017 Semester 2 contact information
Subject Coordinator
Assoc Prof Christine Wright
Dr Graham Mackay
Administrative Coordinator
BiomedSci-AcademicServices@unimelb.edu.au
Time commitment details
170 hours
Last updated: 27 April 2024
Further information
- Texts
Prescribed texts
- Pharmacology, Rang et al., Churchill Livingstone, 6th edition, 2007.
- Principles of Pharmacology, Golan et al., Lippincott, Wilkins & Williams, 2nd edition, 2007.
- Subject notes
This subject is available to students enrolled in the BSc, Biomedicine degree.
- Related Handbook entries
This subject contributes to the following:
Type Name Informal specialisation Biomedical Biotechnology Informal specialisation Microbiology Informal specialisation Biomedical Biotechnology Informal specialisation Microbiology Informal specialisation Science-credited subjects - new generation B-SCI and B-ENG. Major Pharmacology Informal specialisation Selective subjects for B-BMED Major Pharmacology - Breadth options
This subject is available as breadth in the following courses:
- Available through the Community Access Program
About the Community Access Program (CAP)
This subject is available through the Community Access Program (also called Single Subject Studies) which allows you to enrol in single subjects offered by the University of Melbourne, without the commitment required to complete a whole degree.
Entry requirements including prerequisites may apply. Please refer to the CAP applications page for further information.
Last updated: 27 April 2024